Alphabet Inc. - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 89 filers reported holding SPERO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.

Quarter-by-quarter ownership
Alphabet Inc. ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,076,874
-16.6%
889,9790.0%0.07%0.0%
Q2 2023$1,290,469
-0.0%
889,9790.0%0.07%
-4.2%
Q1 2023$1,290,470
-16.2%
889,9790.0%0.07%
-19.1%
Q4 2022$1,539,664
-13.5%
889,9790.0%0.09%
-2.2%
Q3 2022$1,780,000
+170.1%
889,9790.0%0.09%
+152.8%
Q2 2022$659,000
-91.5%
889,9790.0%0.04%
-85.7%
Q1 2022$7,743,000
-45.7%
889,9790.0%0.25%
-27.0%
Q4 2021$14,249,000
-13.0%
889,9790.0%0.34%
-11.6%
Q3 2021$16,385,000
+31.9%
889,9790.0%0.39%
+53.8%
Q2 2021$12,424,000
-5.2%
889,9790.0%0.25%
-52.1%
Q1 2021$13,100,000
-24.1%
889,9790.0%0.53%
-36.2%
Q4 2020$17,257,000
+39.0%
889,979
-20.0%
0.83%
+42.0%
Q3 2020$12,415,000
-17.5%
1,112,4730.0%0.58%
-16.1%
Q2 2020$15,052,000
+67.4%
1,112,4730.0%0.70%
+17.8%
Q1 2020$8,989,000
-16.0%
1,112,4730.0%0.59%
-8.8%
Q4 2019$10,696,000
-9.3%
1,112,4730.0%0.65%
+82.8%
Q3 2019$11,792,000
-7.9%
1,112,4730.0%0.35%
+45.7%
Q2 2019$12,805,000
-10.1%
1,112,4730.0%0.24%
-67.0%
Q1 2019$14,251,000
+108.3%
1,112,4730.0%0.74%
-9.0%
Q4 2018$6,842,000
-41.5%
1,112,4730.0%0.81%
-27.8%
Q3 2018$11,692,000
-28.4%
1,112,4730.0%1.12%
-18.3%
Q2 2018$16,320,000
+2.9%
1,112,4730.0%1.37%
-46.8%
Q1 2018$15,853,000
+21.3%
1,112,4730.0%2.58%
-27.3%
Q4 2017$13,072,0001,112,4733.55%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,932,209$76,246,00015.85%
Atlas Venture Associates XI, LLC 1,376,968$26,700,0004.23%
Atlas Venture Associates IX, LLC 1,376,968$26,700,0004.23%
BVF INC/IL 2,243,278$43,497,0001.71%
AWM Investment Company, Inc. 372,755$7,228,0000.92%
Alphabet Inc. 889,979$17,257,0000.83%
Rock Springs Capital Management LP 1,235,000$23,947,0000.51%
Novo Holdings A/S 576,702$11,182,0000.48%
Artal Group S.A. 500,000$9,695,0000.21%
Granahan Investment Management 420,320$8,150,0000.18%
View complete list of SPERO THERAPEUTICS INC shareholders